APA (7th ed.) Citation

Grätz, C., Changoer, P., Chiang, D. M., Kersting, J., Jaeger, M., Netea-Maier, R., . . . Pfaffl, M. W. (2025). Extracellular vesicle-associated transcriptomic and proteomic biomarkers show in vitro potential for vandetanib treatment monitoring in anaplastic thyroid cancer. Scientific Reports, 14(1), 1. https://doi.org/10.1038/s41598-025-18319-w

Chicago Style (17th ed.) Citation

Grätz, Christian, et al. "Extracellular Vesicle-associated Transcriptomic and Proteomic Biomarkers Show in Vitro Potential for Vandetanib Treatment Monitoring in Anaplastic Thyroid Cancer." Scientific Reports 14, no. 1 (2025): 1. https://doi.org/10.1038/s41598-025-18319-w.

MLA (9th ed.) Citation

Grätz, Christian, et al. "Extracellular Vesicle-associated Transcriptomic and Proteomic Biomarkers Show in Vitro Potential for Vandetanib Treatment Monitoring in Anaplastic Thyroid Cancer." Scientific Reports, vol. 14, no. 1, 2025, p. 1, https://doi.org/10.1038/s41598-025-18319-w.